drugset / Trial / NCT04080609
DDI Study Between Dorzagliatin and Rifampicin
SequentialOpen-labelTreatment
Summary
The purpose of this drug-drug interaction study is to investigate the impact of rifampicin on the pharmacokinetics of Dorzagliatin.
Timeline
- Start
- 2018-03-27
- Primary completion
- 2018-04-17
- Completion
- 2018-04-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dorzagliatin | Small molecule | — | — |
Indications
No indication recorded.